Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Michael Fehlings

6PUBLICATIONS

22CO-AUTHORS

Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Innate immunityPredictive and prognostic markersHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (6)

Sort by Publication Date:

|Mar 14, 2025

PIPLOM: prediction of exogenous peptide loading on major histocompatibility complex class I molecules.

Florian Schmidt, Kanxing Wu, Lorenz Gerber

|Apr 27, 2024

Innate Responses to the Former COVID-19 Vaccine Candidate CVnCoV and Their Relation to Reactogenicity and Adaptive Immunogenicity.

Olaf-Oliver Wolz, Dominik Vahrenhorst, Gianluca Quintini

|Aug 22, 2023

Longitudinal high-dimensional analysis identifies immune features associating with response to anti-PD-1 immunotherapy.

Elaine Lai-Han Leung, Run-Ze Li, Xing-Xing Fan

|Aug 18, 2022

Single-cell analysis reveals clonally expanded tumor-associated CD57<sup>+</sup> CD8 T cells are enriched in the periphery of patients with metastatic urothelial cancer responding to PD-L1 blockade.

Michael Fehlings, Leesun Kim, Xiangnan Guan

|Jul 28, 2018

Author Correction: Checkpoint blockade immunotherapy reshapes the high-dimensional phenotypic heterogeneity of murine intratumoural neoantigen-specific CD8<sup>+</sup> T cells.

M Fehlings, Y Simoni, H L Penny

|Sep 17, 2017

Checkpoint blockade immunotherapy reshapes the high-dimensional phenotypic heterogeneity of murine intratumoural neoantigen-specific CD8<sup>+</sup> T cells.

M Fehlings, Y Simoni, H L Penny

Pageof 1

Frequent Collaborators

3 joint publications

Evan W Newell

2 joint publications

S C Wong

1 joint publications

Alireza Tafazzol

1 joint publications

Oliver A Zill

1 joint publications

Mahesh Yadav

1 joint publications

Elaine Lai-Han Leung

1 joint publications

Hermi Sumatoh

1 joint publications

Alessandra Nardin

1 joint publications

Yabing Cao

1 joint publications

Liang Liu

Frequent Collaborators

3 joint publications

Evan W Newell

2 joint publications

S C Wong

1 joint publications

Alireza Tafazzol

1 joint publications

Oliver A Zill

Top Related Videos

A High Throughput MHC II Binding Assay for Quantitative Analysis of Peptide Epitopes

A High Throughput MHC II Binding Assay for Quantitative Analysis of Peptide Epitopes

Published on : Mar 25, 2014

Rapid <em>In Vivo</em> Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development

Rapid <em>In Vivo</em> Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development

Published on : Jun 19, 2018

Predictive Immune Modeling of Solid Tumors

Predictive Immune Modeling of Solid Tumors

Published on : Feb 25, 2020

See more related videos

Top Related Videos

A High Throughput MHC II Binding Assay for Quantitative Analysis of Peptide Epitopes

A High Throughput MHC II Binding Assay for Quantitative Analysis of Peptide Epitopes

Published on : Mar 25, 2014

Rapid <em>In Vivo</em> Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development

Rapid <em>In Vivo</em> Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development

Published on : Jun 19, 2018

Predictive Immune Modeling of Solid Tumors

Predictive Immune Modeling of Solid Tumors

Published on : Feb 25, 2020

See more related videos